Cargando…

NFB-13. TRAMETINIB FOR PLEXIFORM NEUROFIBROMA AND RECURRENT LOW-GRADE GLIOMA

BACKGROUND: Based on early clinical efficacy data, Seattle Children’s established a standard clinical practice for MEK inhibitor therapy for children with plexiform neurofibroma (PN) or recurrent low-grade glioma (LGG). METHODS: Data were collected under an IRB-approved retrospective chart review. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Aimee, Millard, Nathan, Perez, Francisco, Vitanza, Nicholas, Leary, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715321/
http://dx.doi.org/10.1093/neuonc/noaa222.616

Ejemplares similares